A European Medicines Agency (EMA) panel on Friday recommended approving a potential blockbuster drug from Shire Plc to treat patients aged 12 and older with a rare hereditary disease that causes swelling in different parts of the body.
from Reuters: Health News https://ift.tt/2AiEW0U
No comments:
Post a Comment